Best savings accounts that offer above inflation rates

How to earn the most interest on your savings

Keros Therapeutics, Inc. (KROS)

NasdaqGM - NasdaqGM Real-time price. Currency in USD

Add to watchlist

54.27

-3.33

(-5.78%)

At close: 04:00PM EDT

54.27

0.00

(0.00%)

After hours:

04:02PM EDT

Loading interactive chart…

GuruFocus.com
Keros Therapeutics Reports Widening Losses in Q1 2024, Despite Progress in Clinical Trials
Financial Performance Misses Analyst Forecasts Amid Increased R&D Investments
GlobeNewswire
Keros Therapeutics Reports Recent Business Highlights and First Quarter 2024 Financial Results
LEXINGTON, Mass., May 08, 2024 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros” or the “Company”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapeutics to treat a wide range of patients with disorders that are linked to dysfunctional signaling of the transforming growth factor-beta (“TGF-ß”) family of proteins, today provided a business update and reported financial results for the quarter ended March 31, 2024. “Keros remaine
Simply Wall St.
Are Investors Undervaluing Keros Therapeutics, Inc. (NASDAQ:KROS) By 37%?
Key Insights Keros Therapeutics' estimated fair value is US$93.42 based on 2 Stage Free Cash Flow to Equity Current...